Israel Englander Astrazeneca PLC Put Options Transaction History

Millennium Management LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$76.67 - $87.62 $49.3 Million - $56.4 Million	-643,200 Reduced 78.81%	172,900 $13.5 Million
Q2 2024 Aug 14, 2024	BUY	$66.81 - $80.83 $40.7 Million - $49.3 Million	609,600 Added 295.21%	816,100 $63.6 Million
Q1 2024 May 15, 2024	BUY	$61.03 - $69.57 $6.48 Million - $7.39 Million	106,200 Added 105.88%	206,500 $14 Million
Q4 2023 Feb 14, 2024	SELL	$61.89 - $69.28 $45.7 Million - $51.2 Million	-738,900 Reduced 88.05%	100,300 $6.76 Million
Q2 2023 Aug 14, 2023	BUY	$69.91 - $75.81 $56.5 Million - $61.3 Million	808,000 Added 2589.74%	839,200 $60.1 Million
Q1 2023 May 15, 2023	SELL	$63.15 - $71.6 $9.02 Million - $10.2 Million	-142,900 Reduced 82.08%	31,200 $2.17 Million
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $4.43 Million - $5.76 Million	81,800 Added 88.62%	174,100 $11.8 Million
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $471,878 - $1.21 Million	-8,900 Reduced 8.79%	92,300 $5.06 Million

1,359

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.